1.Grundy, SM, Cleeman, JI, Merz, CN, Brewer, HB Jr, Clark, LT, Hunninghake, DB, Pasternak, RC, Smith, SC Jr & Stone, NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227–239.
2.Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (2003) European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 10, Suppl. 1, S1–S78.
3.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
4.Satoh, H, Nishino, T, Tomita, K & Tsutsui, H (2006) Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men: results from a 10-year cohort study. Circ J 70, 227–231.
5.Achari, V & Thakur, AK (2004) Association of major modifiable risk factors among patients with coronary artery disease – a retrospective analysis. J Assoc Physicians India 52, 103–108.
6.Kwiterovich, PO Jr, Coresh, J, Smith, HH, Bachorik, PS, Derby, CA & Pearson, TA (1992) Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol 69, 1015–1021.
7.Boden, WE (2000) High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trail. Am J Cardiol 86, 19L–22L.
8.Sharrett, AR, Ballantyne, CM, Coady, SA, Heiss, G, Sorlie, PD, Catellier, D & Patsch, W, Atherosclerosis Risk in Communities Study Group (2001) Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104, 1108–1113.
9.Sociedade Brasileira de Cardiologia (2001) III Diretrizes Brasileiras Sobre Dislipidemias e Diretrizes de Prevenção da Aterosclerose. Arq Bras Cardiol 77, Suppl. III, 1–48.
10.Bermudez, OI, Velez-Carrasco, W, Schaefer, EJ & Tucker, KL (2002) Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes. Am J Clin Nutr 76, 1214–1221.
11.Srinivasan, SR, Freedman, DS, Webber, LS & Berenson, GS (1987) Black–white differences in cholesterol levels of serum high-density lipoprotein subclasses among children: the Bogalusa Heart Study. Circulation 76, 272–279.
12.Nethononda, MR, Essop, MR, Mbewu, AD & Galpin, JS (2004) Coronary artery disease and risk factors in Black South Africans – a comparative study. Ethn Dis 14, 515–519.
13.People’s Republic of China–United States Cardiovascular and Cardiopulmonary Epidemiology Research Group (1992) An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People’s Republic of China. Baseline report from the PRC–USA Collaborative Study. Circulation 85, 1083–1096.
14.Lyu, LC, Yeh, CY, Lichtenstein, AH, Li, Z, Ordovas, JM & Schaefer, EJ (2001) Association of sex, adiposity, and diet with HDL subclasses in middle-aged Chinese. Am J Clin Nutr 74, 64–71.
15.Yang, YX, Wang, GY & Pan, XC (2002) The 2002 Chinese Food Composition Table. Beijing: Medical Publishing House of Beijing University.
16.Paffenbarger, RS, Wing, AL & Hyde, RT (1978) Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 108, 161–175.
17.Yin, R, Chen, Y, Pan, S et al. (2006) Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations. Arch Med Res 37, 787–793.
18.Yin, R, Wang, Y, Chen, G, Lin, W, Yang, D & Pan, S (2006) Lipoprotein lipase gene polymorphism at Pvu II locus and serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations. Clin Chem Lab Med 44, 1416–1421.
19.Ruixing, Y, Limei, Y, Yuming, C, Dezhai, Y, Weixiong, L, Muyan, L, Fengping, H, Jinzhen, W, Guangqing, Y & Zhenbiao, N (2006) Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens Res 29, 423–432.
20.Ruixing, Y, Jiaqiang, D, Dezhai, Y, Weixiong, L, Shangling, P, Jinzhen, W, Jiandong, H & Xiuyan, L (2006) Effects of demographic characteristics, health-related behaviors and lifestyle factors on the prevalence of hypertension for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations. Kidney Blood Press Res 29, 312–320.
21.Cooperative Meta-analysis Group of China Obesity Task Force (2002) Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol 23, 5–10.
22.von Kamp, A & Schuster, S (2006) Metatool 5.0: fast and flexible elementary modes analysis. Bioinformatics 22, 1930–1931.
23.Dong, W, Ma, X, Zhang, D & Yu, S (2002) Effect of maize embryo on delaying aging. Food Sci 23, 95–97.
24.Jenkins, DJ, Kendall, CW, Axelsen, M, Augustin, LS & Vusksan, V (2000) Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease. Curr Opin Lipidol 11, 49–56.
25.Lairon, D (1996) Dietary fibres: effects on lipid metabolism and mechanisms of action. Eur J Clin Nutr 50, 125–133.
26.Liu, Y, Zhang, L & Wu, Y (1995) The dietary therapy for hyperlipidemia complicated with NIDDM. Chin J Clin Nutr 3, 174–176.
27.Zhang, Y, Zhou, Y, Wu, F & Zhang, M (1996) The comparative effects of maize oil and lard on blood lipids serum glucose and brain lipofuscin in rats. Acta Nutrimenta Sinica 18, 274–279.
28.Anderson, JW, Johnstone, BM & Cook-Newell, ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333, 276–282.
29.Zhang, HW, Zhang, YH, Lu, MJ, Tong, WJ & Cao, GW (2007) Comparison of hypertension, dyslipidaemia and hyperglycaemia between buckwheat seed-consuming and non-consuming Mongolian-Chinese populations in Inner Mongolia, China. Clin Exp Pharmacol Physiol 34, 838–844.
30.Ludvik, BH, Mahdjoobian, K, Waldhaeusl, W, Hofer, A, Prager, R, Kautzky-Willer, A & Pacini, G (2002) The effect of Ipomoea batatas (caiapo) on glucose metabolism and serum cholesterol in patients with type 2 diabetes: a randomized study. Diabetes Care 25, 239–240.
31.Ludvik, B, Neuffer, B & Pacini, G (2004) Efficacy of Ipomoea batatas (caiapo) on diabetes control in type 2 diabetic subjects treated with diet. Diabetes Care 27, 436–440.
32.al-Zuhair, H, Abd el-Fattah, AA & Abd el Latif, HA (1997) Efficacy of simvastatin and pumpkin-seed oil in the management of dietary-induced hypercholesterolemia. Pharmacol Res 35, 403–408.
33.Zhang, Y & Wang, ZZ (2006) GC–MS analysis of fat-soluble constituents of hemp kernels. Acta Bot Boreal Occident Sin 26, 1955–1958.
34.Ross, SA, Mehmedic, Z, Murphy, TP & Elsohly, MA (2000) GC–MS analysis of the total Δ9-THC content of both drug- and fiber-type cannabis seeds. J Anal Toxicol 24, 715–717.
35.Zhou, YH (2004) Analysis of fatty acid in hemp fruit oil with GC–MS. Chin Oils Fats 29, 72–73.
36.Ren, HY, Sun, HG, Ma, JZ, Zhang, Y, Yi, CR, Wu, MX, Liu, WL & Li, GL (1997) Experimental study on the effects of hemp fruit oil on serum lipid levels and lipid peroxidation. Chin J Tradit Med Sci Technol 4, 200.
37.Ren, HY, Sun, HG, Zhang, Y, Yi, CR, Wu, MX, Li, GL & Liu, WL (1998) Lipid-lowering and antiatherosclerotic effects of hemp fruit oil in partridges. Henan Tradit Chin Med 18, 294–295.
38.Schwab, US, Callaway, J, Erkkila, AT, Gynther, J, Uusitupa, MI & Jarvinen, T (2006) Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic factors. Eur J Nutr 45, 470–477.
39.Yu-Poth, S, Zhao, G, Etherton, T, Naglak, M, Jonnalagadda, S & Kris-Etherton, P (1999) Effects of National Cholesterol Education Program’s Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 69, 632–646.
40.Mudali, S, Dobs, AS, Ding, J, Cauley, JA, Szklo, M & Golden, SH, Atherosclerosis Risk in Communities Study (2005) Endogenous postmenopausal hormones and serum lipids: the Atherosclerosis Risk in Communities Study. J Clin Endocrinol Metab 90, 1202–1209.
41.Cheung, AP (2000) Acute effects of estradiol and progesterone on insulin, lipids and lipoproteins in postmenopausal women: a pilot study. Maturitas 35, 45–50.
42.Karki, DB, Neopane, A, Pradhan, B & Magar, A (2004) Lipid levels in Nepalese population. Kathmandu Univ Med J (KUMJ) 2, 349–353.
43.Guize, L, Benetos, A, Thomas, F, Malmejac, A & Ducimetiere, P (1998) Cholesterolemia and total, cardiovascular and cancer mortality. Study of a cohort of 220,000 people. Bull Acad Natl Med 182, 631–650.
44.Li, D, Yu, XM, Zhou, XQ, Zhang, YH, Yao, T & Sinclair, AJ (2004) Relationship between BMI and serum and lipoprotein lipids in the Hangzhou region. Asia Pac J Clin Nutr 13, S68.
45.Mataix, J, Lopez-Frias, M, Martinez-de-Victoria, E, Lopez-Jurado, M, Aranda, P & Llopis, J (2005) Factors associated with obesity in an adult Mediterranean population: influence on plasma lipid profile. J Am Coll Nutr 24, 456–465.
46.Kawada, T (2002) Body mass index is a good predictor of hypertension and hyperlipidemia in a rural Japanese population. Int J Obes Relat Metab Disord 26, 725–729.
47.Houston, MC, Basile, J, Bestermann, WH et al. (2005) Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci 329, 276–291.
48.Pei, D, Kuo, SW, Wu, DA, Lin, TY, Hseih, MC, Lee, CH, Hsu, WL, Chen, SP, Sheu, WH & Li, JC (2005) The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians. Int J Clin Pract 59, 1408–1416.
49.Catalano, M, Aronica, A, Carzaniga, G, Seregni, R & Libretti, A (1991) Serum lipids and apolipoproteins in patients with essential hypertension. Atherosclerosis 87, 17–22.
50.Bonaa, KH & Thelle, DS (1991) Association between blood pressure and serum lipids in a population. The Tromso Study. Circulation 83, 1305–1314.
51.Li, J, Niu, Q, Li, P, Wang, S & Zhao, S (1991) The levels of serum lipids, lipoprotein, and apolipoprotein in patients with essential hypertension. Chin J Cardiol 19, 317–319.
52.Borghi, C, Dormi, A, Veronesi, M, Sangiorgi, Z & Gaddi, A; Brisighella Heart Study Working Party (2004) Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J 148, 285–292.
53.Corella, D, Tucker, K, Lahoz, C, Coltell, O, Cupples, LA, Wilson, PW, Schaefer, EJ & Ordovas, JM (2001) Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. Am J Clin Nutr 73, 736–745.